Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

13 results about "Tubule" patented technology

A tubule is: a small tube or fistular structure a minute tube lined with glandular epithelium any hollow cylindrical body structure a minute canal found in various structures or organs of the body a slender elongated anatomical channel

Method and apparatus using computational pathology for risk stratification of cancer

The present disclosure relate to a method. The method includes accessing segmented digitized pathology imaging data from a cancer patient. The segmented digitized pathology imaging data identifies segmented nuclei, segmented mitosis, and segmented tubule regions. A plurality of nuclear features are extracted using the segmented nuclei. A plurality of mitosis features are extracted using the segmented mitosis. A plurality of tubule features are extracted using the segmented tubule regions. A risk score is generated by operating a machine learning model on the plurality of nuclear features, the plurality of mitosis features, and the plurality of tubule features. The risk score correlates to a risk of recurrence of cancer for the cancer patient.
Owner:CASE WESTERN RESERVE UNIV +1

System and method for determining a cardiomyocyte manganese ion uptake rate constant to indicate a t-tubule density

PCT designated stage expiredWO2024258292A1Image enhancementMedical imagingLeft ventricular sizeHematocrit Measurement
A method, CRM and system for determining a cardiomyocyte manganese ion uptake rate constant in one or more regions of interest in a heart of a subject comprising: a providing step comprising: providing a left ventricular myocardial image slice covering one or more regions of interest taken during a first time period; providing one or more longitudinal relaxation time weighted images of the left ventricular blood pool taken during the first time period to measure an average signal intensity in blood during the first time period; providing a hematocrit measurement; providing an extracellular volume measurement for each of the one or more regions of interest; an administration step comprising administering a contrast agent comprising manganese 2+ ions; an image acquisition step comprising: performing image acquisition of the left ventricular blood pool using a longitudinal relaxation time weighted pulse sequence at a plurality of time intervals during a second time period to measure respective signal intensities in blood at the plurality of time intervals; performing a longitudinal relaxation time map image acquisition of a left ventricular myocardial image slice covering the one or more regions of interest during a third time period; a measurement step comprising measuring a signal intensity in blood at each of the plurality of time intervals using an image taken at a time point within said corresponding time interval; and a calculation step comprising: calculating a change in a myocardial longitudinal relaxation rate for each region of interest from a baseline myocardial longitudinal relaxation rate extracted from the myocardial image slice taken during the first time period and a myocardial longitudinal relaxation rate at an end time point of an MRI examination extracted from the myocardial image slice during the third time period; calculating a blood longitudinal relaxation rate for each of the plurality of time intervals using respective signal intensities in blood at the plurality of time intervals and a relationship between signal intensity and said plurality of relaxation rates using the integral over all the changes in blood longitudinal relaxation rate in conjunction with the myocardial longitudinal relaxation rate at the end time point in a proportionality relationship with a cardiomyocyte Mn2+ uptake rate constant to estimate the cardiomyocyte Mn2+ uptake rate constant for each of the one or more regions of interest; wherein said first time period is before an administration of the contrast agent, said second time period is during and after an administration of the contrast agent, and said third time period encompasses the end timepoint of an MRI examination.
Owner:IC TARGETS

Proximal tubule biomimetic system

To provide a biomimetic system that mimics the human proximal tubule, which is a high-performance in vitro model that can reproduce the physiological functions of the human proximal tubule in vitro and can be used as an evaluation tool in drug discovery.SOLUTION: The present invention provides a proximal tubule biomimetic system comprising a microfluidic device and LTL-positive cells derived from pluripotent stem cells contained within the microfluidic device. The microfluidic device has (A) a device body, (B) a first chamber provided in the device body, (C) a second chamber provided in the device body, and (D) a porous membrane positioned between the first chamber and the second chamber, separating the first chamber from the second chamber. The LTL-positive cells are contained within the first chamber and adhere to a first surface of the porous membrane facing the first chamber. The first surface of the porous membrane is coated with an extracellular matrix.SELECTED DRAWING: None
Owner:KYOTO UNIV +2

Perfusable 3D tubule-on-chip model derived from kidney organoids with improved drug uptake

Described herein are perfusable 3D tubule-on-chip models comprising at least one tubule consisting of one patent lumen circumscribed by organoid-derived cells, and a multifluidic platform comprising at least one individually addressable chip. The models may further include an unseeded tubule, where the seeded tubule and the unseeded tubule are co-localized on the chip, and wherein the tubule and the unseeded tubule are embedded within a gelatin-fibrin extracellular matrix (ECM). Also, described here are methods of producing the described perfusable 3D tubule-on-chip models, and uses of the same.
Owner:PRESIDENT & FELLOWS OF HARVARD COLLEGE +1

Three-dimensional microcosmic bone fossa-tubule system mass transfer chip and experimental device

The invention discloses a three-dimensional microcosmic bone fossa-tubule system mass transfer chip and an experimental device, and particularly relates to the field of organoids, microfluidics and bone tissue engineering devices. The mass transfer chip comprises an upper cover plate, a plurality of middle plates and a lower cover plate, the upper cover plate is connected with the adjacent middle plates in a bonding mode, the adjacent middle plates are connected in a bonding mode, the middle plates are connected with the lower cover plate in a bonding mode, and the centers of the upper cover plate, the multiple middle plates and the lower cover plate are jointly provided with Harvard pipes in a penetrating mode. A plurality of bone pits which are annularly distributed at intervals are etched in each middle plate, a bone tubule is communicated between every two adjacent bone pits, the bone pits are communicated with the Harvard tube through the bone tubules, and the Harvard tube, the bone pits and the bone tubules are all made of quartz glass. By the adoption of the technical scheme, the problem of existing bone mass transfer experiment research is solved, and the transportation process of a bone fossa-tubule system can be checked.
Owner:浣江实验室 +1

Tracheal catheter connector

The utility model discloses a tracheal catheter connector, which belongs to the technical field of medical equipment and comprises a main body, and a guide wire insertion device is mounted on the main body. The guide wire inserting device comprises a sealing assembly and a self-locking assembly, and the sealing assembly and the self-locking assembly are both connected with the body. By means of the mode, the guide wire inserting device can be connected with a breathing machine while tracheal intubation is carried out, and emergency rescue of a patient is achieved; through the sealing assembly and the self-locking assembly, gas leakage can be prevented when the guide wire is taken out; through the fixing assembly, the guide balloon and the tubule on the tracheal catheter can be fixed, and accidents are prevented.
Owner:CHINESE PEOPLES LIBERATION ARMY ARMY SPECIAL MEDICAL CENTER

Vasculation bone micro-tissue and preparation method thereof

The invention belongs to the technical field of medicine, and discloses a vascularized bone micro-tissue and a preparation method thereof, the vascularized bone micro-tissue comprises umbilical cord mesenchymal stem cell spheres and bone marrow mesenchymal stem cells, and the bone marrow mesenchymal stem cells cover the umbilical cord mesenchymal stem cell spheres to form a core-shell structure. Compared with an anoxic environment, the inside of the micro-tissue sphere of the vascularization bone micro-tissue disclosed by the invention promotes formation of tubules, improves an internal inflammation micro-environment, increases extracellular matrix secretion, provides a good basis for bone mesenchymal stem cells (BMSCs) osteogenic differentiation, constructs a cell growth micro-environment, and accelerates bone regeneration in a stent.
Owner:FIRST HOSPITAL AFFILIATED TO GENERAL HOSPITAL OF PLA

Bone fossa-tubule organ chip and experimental method

The invention discloses a bone fossa-tubule organ-like chip and an experimental method, and particularly relates to the field of organ-like chip technology and bone mass transfer. Comprising an upper cover plate and a lower cover plate which are made of transparent materials, liquid inlet grooves and liquid outlet grooves are formed in the two sides of the lower cover plate respectively, an artificial bone tissue located between the two liquid inlet grooves is etched on the lower cover plate, the artificial bone tissue comprises six longitudinally-arranged Harvard tubes and a plurality of transversely-arranged Forkman tubes, and the Harvard tubes and the Forkman tubes are arranged in a staggered mode. The liquid inlet groove and the liquid outlet groove are communicated through the Harvard tubes, all the formkman tubes are connected between every two adjacent Harvard tubes respectively, and a plurality of bone fossa and bone tubules which are communicated with each other are arranged on the two sides of each Harvard tube. By adopting the technical scheme of the invention, the problems that the experimental sample preparation process is tedious and only the limited depth can be observed in the existing in-vitro experimental method are solved, and the mass transfer law between bone cells is explored.
Owner:浣江实验室 +1

Composition with dental tubule plugging effect and application thereof

The invention relates to a composition with a dental tubule plugging effect and application thereof. The composition comprises hydroxyapatite, arginine and calcium potassium phosphosilicate. The invention creatively finds that the composition is lack of any one of hydroxyapatite, arginine or calcium potassium phosphosilicate, the plugging rate of the dental tubules is obviously reduced, and the hydroxyapatite, arginine and calcium potassium phosphosilicate on the surface have a remarkable synergistic effect in the aspect of the plugging effect of the dental tubules. The composition can well block dental tubules, and has certain enamel repairing and anti-allergy effects.
Owner:SHENZHEN SANBAN TECH CO LTD

Use of hepcidin in preparation of drug for blocking ferroptosis of collecting tubule in acute kidney injuries and protecting kidney function

The present invention belongs to the technical field of medicine. Disclosed in the present invention is a new pharmaceutical use of hepcidin, specifically the use of hepcidin in the preparation of a drug for blocking ferroptosis of a collecting tubule in acute kidney injuries and protecting kidney function. It has been demonstrated in the present invention that both renal endogenous and exogenous hepcidin can alleviate tubular injury and improve renal function in ischemia-reperfusion-induced acute kidney injury by inhibiting ferroptosis in intercalated cells of the collecting tubule. Disclosed in the present invention is a drug for alleviating ferroptosis of a collecting tubule and protecting kidney function in ischemic-reperfusion-induced acute kidney injury. The drug is an intraperitoneal injection prepared by dissolving hepcidin at a therapeutic concentration in PBS.
Owner:SOUTHEAST UNIV

Nouvelle comfort papanicolaou (PAP) brush

A cytological collection tool comprising a handle attached at its distal end to a base that includes a head from which broom-like tubules protrude and are arranged to form an elongated central portion and from which an arrangement of brush-like fibers protrude from the central portion.
Owner:BROMAN STEVEN D

A three-dimensional microscopic bone lacuna-tubule system mass transfer chip and experimental device

The present invention patent discloses a three-dimensional microscopic bone lacuna-tubule system mass transfer chip and experimental device, specifically relating to the fields of organoids, microfluidics, and bone tissue engineering devices. The mass transfer chip includes an upper cover plate, multiple intermediate plates, and a lower cover plate. The upper cover plate is connected to adjacent intermediate plates, adjacent intermediate plates, and the intermediate plate to the lower cover plate by bonding. The centers of the upper cover plate, multiple intermediate plates, and lower cover plate are all pierced with Haversian tubes. Each intermediate plate is etched with multiple bone lacunas spaced in an annular pattern. Bone canaliculi connect two adjacent bone lacunas. The bone canaliculi connect the bone lacunas to the Haversian tubes. The Haversian tubes, bone lacunas, and bone canaliculi are all made of quartz glass. The technical solution of the present invention solves the problems of existing bone mass transfer experimental research and can examine the transport process of the bone lacuna-tubule system.
Owner:浣江实验室 +1

Scalable and highly accurate context-guided segmentation of histological structures, including tubules / glands and lumens, tubule / glandular clusters, and individual nuclei, in full-slide images of tissue samples from a spatial multi-parameter cell / intracellular imaging platform.

To provide a method and system that segment one or more histological structures in a tissue image represented by multi- parameter cellular and intracellular imaging data.SOLUTION: A method of segmenting one or more histological structures in a tissue image represented by multi-parameter cellular and intracellular imaging data includes: receiving coarsest level image data on a tissue image, in which the coarsest level image data corresponds to the coarsest level of a multiscale representation of first data corresponding to the multi-parameter cellular and intracellular imaging data; further dividing the coarsest level image data into a plurality of non-overlapping superpixels; assigning, to each superpixel, a probability belonging to the one or more histological structures using some pre-trained machine learning algorithms to create a probability map; extracting an estimation boundary of the one or more histological structures by applying a contour algorithm to the probability map; and generating an accurate boundary of the one or more histological structures using the estimation boundary.SELECTED DRAWING: Figure 1
Owner:UNIV OF PITTSBURGH OF THE COMMONWEALTH SYST OF HIGHER EDUCATION